Suki secures $90 million to expand its healthcare AI platform. 14 October 2026 Key Takeaways * Suki secured $90 million in Series E financing to expand its healthcare AI capabilities. * Patient encounters supported by Suki grew more than 190% year over year in 2026. * The company plans to deepen technology partnerships and develop AI agents for clinical workflows. Suki secures $90 million to advance healthcare AI. Suki has secured $90 million in Series E financing to accelerate growth and expand its healthcare AI platform. The round attracted new investors Healthier Capital, Crosslink Capital, and Hercules Capital. Existing institutional investors also participated. Venrock, Flare Capital Partners, Hedosophia, Philips Ventures, and Zoom Ventures are some of its investors. It intends to invest in AI, commercial growth and its ecosystem of partners. Its original focus was ambient clinical intelligence and automated medical documentation. It has to this point expanded into areas like clinical reasoning, revenue cycle management, and all the way into day-to-day operations workflows. Its broader goal is to connect intelligence across healthcare systems. The company serves more than 450 healthcare organisations through its clinician-facing application. More than 30 technology partners also integrate Suki's AI into their platforms. These partnerships help bring its capabilities into tools healthcare teams already use. Rather than simply adding more partners, Suki wants to deepen existing integrations. Suki expands beyond clinical documentation. Suki is developing its platform to support more than recording patient conversations. Its tools can generate clinical notes, suggest billing codes, support order entry, and summarise patient information. The company recently introduced Ask, which brings clinical knowledge from Wolters Kluwer's UpToDate Expert AI into clinicians' workflows. The feature supports clinical questions using trusted medical knowledge and relevant patient information. Suki also plans to develop AI agents that handle tasks after patient visits. These could include coordinating referrals and managing prior authorisations for medications. The company intends to use information from its existing tools to support these activities. Suki reports strong growth across healthcare. Suki reports rising healthcare adoption, doubling revenue and expanding technology partnerships as its AI-powered platform supports more patient encounters and clinical workflows. Source: Created by Ventureburn. Suki's latest financing follows significant growth in adoption and commercial performance. Patient encounters supported by its technology increased more than 190% year over year in 2026. Revenue doubled in 2025 and is on track for similar growth in 2026. Revenue from Suki's partner business has also increased more than tenfold over the past two years. The company now works with more than 30 technology partners. These include platforms that integrate its AI into existing clinical and telehealth workflows. Healthier Capital Partner Aman Mahajan will join Suki's board of directors. He brings experience across clinical medicine, healthcare technology, and health system leadership. His previous roles include positions at UPMC and UCLA Health. This strategy could bring more of its capabilities into platforms already used by healthcare organisations. New funding supports AI agents and deeper integrations. Suki will use the new capital to strengthen its AI technology, integrations, and commercial organisation. It also plans to expand the capabilities available through its partner network. This strategy aims to connect clinical, financial, and operational workflows. Founder and CEO Punit Soni believes healthcare needs more than disconnected AI tools. He sees an opportunity to build an intelligent operating system for healthcare. Such a system could help clinicians and organisations complete work across the care journey. Suki also highlights the financial value of its technology. According to results validated by KLAS, the average monthly financial impact is over $2,600 per provider. The company claims less time on documentation and less work hours outside the office. The funding comes as healthcare AI technology is expanding out of documentation and into broader clinical operations. Suki intends to build tools to assist clinicians and technology partners. Its next step will be further integrations and more advanced AI agents. To stay updated on crypto venture capital funding and market trends, visit its venture capital news section for more insights. Clinton Nwachukwu is a crypto and finance writer with an MBA in Artificial Intelligence and 6+ years of experience creating content for leading global brands. He turns complex topics into clear, actionable insights for readers worldwide. Disclaimer VentureBurn is a media platform covering the latest in cryptocurrency, artificial intelligence, venture capital, and the startup ecosystem. Opinions expressed on VentureBurn are for informational purposes only and do not constitute investment advice. Before making any high-risk investments in digital assets or emerging technologies, readers should conduct their own due diligence. All transactions and financial decisions are made at your own risk, and any losses incurred are solely your responsibility. VentureBurn does not endorse or recommend the buying or selling of any digital assets and is not a licensed investment advisor. Please note that VentureBurn may participate in affiliate marketing programs.

Heartland Dental buys 33 practices; bond selloff deepens. Heartland Dental acquires Foundation Dental Partners, BlackRock enters CenterWell deal, and Ray Dalio warns the Treasury selloff has far to go. October 13, 2026 This week in brief * Healthcare Practice & Business Deals: Three notable transactions headline this week's healthcare deal activity, spanning dental DSO roll-ups, senior primary care, and AI-driven health technology. * Global Markets & Macro: Markets face a turbulent week as a chip selloff, rising bond yields, and the start of earnings season converge. Healthcare Practice & Business Deals. Three notable transactions headline this week's healthcare deal activity, spanning dental DSO roll-ups, senior primary care, and AI-driven health technology. Heartland Dental acquires Foundation Dental Partners. Heartland Dental has added Foundation Dental Partners and its 33 supported practices to its growing portfolio. The deal extends a 13-month acquisition run that also included Smile Design Dentistry and its 60 supported practices, Inspire Dental of NC, and nearly two dozen solo practices. No financial terms were disclosed. Heartland is one of the nation's largest dental support organizations, and the Foundation deal reinforces the ongoing DSO consolidation trend. BlackRock takes majority stake in Humana's CenterWell clinics. Humana announced a $2.8 billion joint venture with BlackRock, giving the investment firm a majority stake in nearly 150 CenterWell senior primary care clinics. The deal replaces Humana's prior partnership with Welsh, Carson, Anderson & Stowe. Humana retains an ongoing role in the venture. The transaction signals continued institutional appetite for senior-focused primary care assets. Suki raises $90 million in Series E funding. AI clinical documentation company Suki closed a $90 million Series E round. The company says it will use the capital to develop AI agents and deepen relationships with its 30 health technology partners. The raise came less than a week after Suki launched a new AI capability. While not a practice acquisition, the round reflects accelerating private investment in AI infrastructure for healthcare settings. Global Markets & Macro. Markets face a turbulent week as a chip selloff, rising bond yields, and the start of earnings season converge. AI chip selloff rattles equities. A deepening selloff in chipmakers drove broad equity weakness as Wall Street kicked off earnings season. Concerns about the sustainability of the artificial-intelligence trade weighed on both US stocks and emerging markets. The AI-linked decline sent emerging-market equities toward their worst single session since July, also pressuring currency markets globally. Ray Dalio warns the Treasury selloff has further to run. Billionaire investor Ray Dalio cautioned that the US bond market decline is far from over. He pointed to surging government and corporate borrowing colliding with weakening demand from some of the world's largest traditional buyers. Trending commentary across financial media echoes this concern, with many analysts flagging systemic risk in the Treasury market and the growing burden of US debt obligations. Big bank earnings boost equities desks. JPMorgan Chase and Goldman Sachs reported strong quarterly results, lifted by their equities businesses. Meanwhile, fixed-income trading desks struggled in the third quarter, marking a rare quarter where equity traders outshone their bond-market counterparts. The results offered some reassurance, though analysts warn that sustaining S&P 500 earnings momentum will grow harder as the bar rises each quarter. Trump-Russia diesel deal stirs market and political debate. President Trump claimed a deal with Russia to ease a global diesel shortage, with the Treasury Department waiving sanctions to enable Russian exports. Diesel futures dipped after the announcement. However, analysts and market intelligence firms expressed doubt that the volumes involved would meaningfully move US diesel prices. Average US diesel prices remain well above $6 per gallon. The deal also drew bipartisan congressional criticism and legal questions about compliance with existing import bans. IMF upgrades UK growth outlook. The International Monetary Fund upgraded its economic outlook for the United Kingdom, citing the technology and AI sector as a key driver of growth. The fund identified Britain as one of the emerging winners of the global tech boom. Separately, UK Chancellor Jeremy Hunt rejected calls to equalize capital gains and income tax rates, easing concerns among entrepreneurs and investors. What to watch. Dental DSO consolidation shows no sign of slowing, with Heartland's latest acquisition adding to a busy 13-month run. In the capital markets, all eyes remain on whether bank earnings momentum can offset anxiety over the AI trade, rising Treasury yields, and a diesel supply shock that is adding political pressure ahead of US midterm elections. Practice owners and investors alike should monitor interest rate direction closely - Dalio's warning and widespread commentary on debt sustainability suggest the rate environment will remain a key variable in deal financing through year-end. Explore Tenet M&A. Tenet M&A helps physicians and practice owners navigate healthcare M&A. Start here: Editorial note, image use & corrections. This report is compiled and summarized from publicly available news sources; figures and details should be independently verified. Accompanying images are used under Creative Commons or public-domain licenses (sourced via Openverse) and credited where required. If you believe any content - written or image - has been used in error, is inaccurate, or infringes your rights, or you wish to request a correction or removal, please contact Tenetma Report at [email protected] and Tenetma Report will address it promptly. What do these market moves mean for your practice value? Get a confidential read on what your practice is worth in today's market. About Tenet Mergers & Acquisitions Tenet Mergers & Acquisitions is a sell-side advisory firm for healthcare practice owners exploring a sale, partnership or transition. Thinking about selling your medical practice? Get a confidential practice valuation. If you're considering selling your practice - or exploring your options - a confidential valuation is a helpful first step. Understanding market conditions and potential value provides clarity and supports better decisions around timing and strategy.

Suki raises $90M in Series E round to create AI agents. The new funds will be used to build AI agents handling tasks like referrals and prior authorizations and deepen its partnerships with 30-plus technology partners that have embedded its solutions. Published Oct. 13, 2026 By Anuja Vaidya Dive brief: * AI scribe company Suki has raised $90 million in Series E financing as it expands beyond clinical documentation, clinical decision-making support and revenue cycle operations. * The company will use the funds to develop AI agents that can perform tasks like filling orders and scheduling follow-ups, Suki CEO Punit Soni said in an interview. * The company will also use the new funding to scale its partnerships with health technology companies that have embedded Suki's tools into their platforms, including Optum, Zoom and athenahealth. Dive insight: Suki offers various AI-driven tools for healthcare, including ambient listening and transcribing to create clinical notes, automated order entry, billing code suggestions and patient summaries. The company recently launched Suki Ask, which provides AI-generated responses to clinical questions, analyzing information from patient charts and Wolters Kluwer's database of clinical research. The company now plans to build AI agents to complete tasks after the patient visit and treatment plan are completed, such as referrals and prior authorizations for new medications, Soni said. These agents will use information from the company's existing tools to complete the tasks. Suki will also use the new funds to deepen its partnerships with the more than 30 health technology companies that have embedded Suki's solutions into their platform. For instance, athenahealth's Ambient Notes is powered by Suki, as is the ambient documentation feature on the Zoom telehealth platform. With the funding, the company will work with its technology partners to embed additional capabilities from Suki, including the AI agents it plans to build. "We want to go deep with them. We don't want to add 30 more [partners] necessarily; we want to actually go deeper...[and] deepening means taking those features we have built on the Suki app and giving all of them to our partners," Soni said. New investors Healthier Capital, Crosslink Capital and Hercules Capital joined existing investors in the Series E round. As the popularity of AI scribing tools explodes, Suki faces heavy competition in a market where raising hundreds of millions of dollars is not uncommon. Last year, Ambience Healthcare raised $243 million and Abridge secured $300 million, as the companies eyed expansion beyond clinical documentation. In contrast, Suki has raised more than $250 million across its five funding rounds so far. Soni says that raising mega rounds of $100 million or more could create unreasonably high expectations of what the company needs to deliver. "I think you should raise only how much you need," he said. "You should use it only for the things that you can do. Having a little bit of starvation creates discipline."